1. ImmunoGen Appoints Helen M. Thackray, MD to its Board of Directors

    ImmunoGen Appoints Helen M. Thackray, MD to its Board of Directors

    WALTHAM, Mass.--(BUSINESS WIRE)-- ImmunoGen Inc.(Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced the appointment of Helen M. Thackray, MD, FAAP to its Board of Directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned